Suchergebnisse - "Tillett, William"

PubPharm (172)

21

Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA

enthalten in: RMD open | 2023

von Richette, P. | Vis, M. | Ohrndorf, S. | +10

22

Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years : results from BE ACTIVE

enthalten in: Rheumatology (Oxford, England) | 2023

von Mease, P. | Asahina, A. | Gladman, D. | +8

CommentIn: Nat Rev Rheumatol. 2022 Sep;18(9):494. - PMID 35922551

23

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis : a retrospective, observational BADBIR cohort study

enthalten in: RMD open | 2023

von Tillett, W. | Ogdie, A. | Passey, A. | +1

24

Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab : results from a real-world US cohort

enthalten in: Frontiers in medicine | 2023

von Tillett, W. | Birt, J. | Cavanaugh, C. | +5

25

Ustekinumab with or without methotrexate for psoriatic arthritis?

enthalten in: The Lancet. Rheumatology | 2023

von Gollins, C. | Tillett, W.

26

Impact of Physician-Defined Flares on Quality of Life and Work Impairment : An International Survey of 2238 Patients With Psoriatic Arthritis

enthalten in: The Journal of rheumatology | 2023

von Orbai, A. | Tillett, W. | Grieb, S. | +5

27

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

enthalten in: Rheumatology (Oxford, England) | 2022

von Coates, L. | Garrood, T. | Gullick, N. | +8

28

A qualitative study of patients' experiences of screening for psoriatic arthritis

enthalten in: The British journal of dermatology | 2022

von Silverthorne, C. | Bowen, C. | Lord, J. | +4

29

The need for clarity on the use of glucocorticoids for people with psoriatic arthritis : a call for consensus

enthalten in: Rheumatology (Oxford, England) | 2022

von Tillett, W. | Coates, L. | Smith, C.

CommentOn: Rheumatology (Oxford). 2022 Nov 2;61(11):4232-4244. - PMID 35285486

30

The Effect of Guselkumab on General Health State in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Trial

enthalten in: Advances in therapy | 2022

von Curtis, J. | McInnes, I. | Rahman, P. | +11